Bloomage BioTechnology Corporation Limited (688363.SS)
CNY 46.08
(5.18%)
CNY 46.08
(5.18%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 1 Billion CNY | -38.5% |
| 2022 | 1.38 Billion CNY | 28.87% |
| 2021 | 1.06 Billion CNY | 25.29% |
| 2020 | 840.39 Million CNY | 11.4% |
| 2019 | 766.33 Million CNY | 38.22% |
| 2018 | 564.03 Million CNY | 70.76% |
| 2017 | 331.1 Million CNY | -11.55% |
| 2016 | 365.52 Million CNY | 33.77% |
| 2015 | 287.19 Million CNY | 29.1% |
| 2014 | 215.72 Million CNY | 49.5% |
| 2013 | 144.29 Million CNY | 13.06% |
| 2012 | 122.16 Million CNY | 0.0% |
| 2011 | - CNY | 0.0% |
| 2010 | - CNY | 0.0% |
| 2009 | - CNY | 0.0% |
| 2008 | - CNY | 0.0% |
| 2007 | - CNY | 0.0% |
| 2006 | - CNY | 0.0% |
| 2005 | - CNY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q3 | 17.3 Million CNY | -91.38% |
| 2024 Q2 | 179.36 Million CNY | -43.42% |
| 2024 Q1 | 331.97 Million CNY | 111.63% |
| 2023 FY | - CNY | -38.5% |
| 2023 Q2 | 286.29 Million CNY | 16.19% |
| 2023 Q1 | 246.4 Million CNY | -27.59% |
| 2023 Q3 | 97.78 Million CNY | -65.84% |
| 2023 Q4 | 136.91 Million CNY | 40.01% |
| 2022 Q2 | 350.89 Million CNY | 38.89% |
| 2022 Q4 | 340.27 Million CNY | 40.84% |
| 2022 FY | - CNY | 28.87% |
| 2022 Q3 | 241.6 Million CNY | -31.15% |
| 2022 Q1 | 252.64 Million CNY | -8.13% |
| 2021 Q3 | 233.88 Million CNY | 6.12% |
| 2021 FY | - CNY | 25.29% |
| 2021 Q1 | 201.98 Million CNY | -33.57% |
| 2021 Q2 | 220.39 Million CNY | 9.12% |
| 2021 Q4 | 275.01 Million CNY | 17.58% |
| 2020 Q3 | 225.72 Million CNY | 35.13% |
| 2020 Q1 | 140.24 Million CNY | -33.28% |
| 2020 Q2 | 167.04 Million CNY | 19.11% |
| 2020 FY | - CNY | 11.4% |
| 2020 Q4 | 304.07 Million CNY | 34.71% |
| 2019 Q1 | 141.8 Million CNY | -6.34% |
| 2019 Q3 | 186.36 Million CNY | -10.48% |
| 2019 FY | - CNY | 38.22% |
| 2019 Q4 | 210.18 Million CNY | 12.78% |
| 2019 Q2 | 208.17 Million CNY | 46.81% |
| 2018 FY | - CNY | 70.76% |
| 2018 Q4 | 151.39 Million CNY | 39.16% |
| 2018 Q3 | 108.79 Million CNY | -25.37% |
| 2018 Q2 | 145.77 Million CNY | 19.99% |
| 2018 Q1 | 121.49 Million CNY | 0.0% |
| 2017 Q2 | 68.81 Million CNY | 0.0% |
| 2017 Q1 | 68.81 Million CNY | -26.06% |
| 2017 FY | - CNY | -11.55% |
| 2016 Q4 | 93.06 Million CNY | 0.0% |
| 2016 Q2 | 85.78 Million CNY | 0.0% |
| 2016 FY | - CNY | 33.77% |
| 2016 Q3 | 93.06 Million CNY | 8.49% |
| 2016 Q1 | 85.78 Million CNY | 19.1% |
| 2015 Q4 | 72.02 Million CNY | 0.0% |
| 2015 FY | - CNY | 29.1% |
| 2015 Q3 | 72.02 Million CNY | 0.65% |
| 2015 Q2 | 71.56 Million CNY | 0.0% |
| 2015 Q1 | 71.56 Million CNY | 38.97% |
| 2014 Q1 | 56.36 Million CNY | 150.72% |
| 2014 Q3 | 51.5 Million CNY | -8.62% |
| 2014 FY | - CNY | 49.5% |
| 2014 Q4 | 51.5 Million CNY | 0.0% |
| 2014 Q2 | 56.36 Million CNY | 0.0% |
| 2013 Q2 | 49.66 Million CNY | 0.0% |
| 2013 Q3 | 22.47 Million CNY | -54.74% |
| 2013 Q4 | 22.47 Million CNY | 0.0% |
| 2013 FY | - CNY | 13.06% |
| 2013 Q1 | 49.66 Million CNY | 92.21% |
| 2012 FY | - CNY | 0.0% |
| 2012 Q4 | 25.84 Million CNY | 0.0% |
| 2012 Q3 | 25.84 Million CNY | 0.0% |
| 2011 FY | - CNY | 0.0% |
| 2010 FY | - CNY | 0.0% |
| 2009 FY | - CNY | 0.0% |
| 2008 FY | - CNY | 0.0% |
| 2007 FY | - CNY | 0.0% |
| 2006 FY | - CNY | 0.0% |
| 2005 FY | - CNY | 0.0% |